Long Non-Coding RNA MALAT1 as a Detection and Diagnostic Molecular Marker in Various Human Cancers: A Pooled Analysis Based on 3255 Subjects
Authors:
Open Access
- 1 June 2020
- journal article
- review article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 13, 5807-5817
Abstract
Purpose: Accumulating studies have explored the potential diagnostic value of lncRNA MALAT1 in various cancers. However, there are still inconsistent results in diagnostic accuracy and reliability in individual studies. The aim of this pooled study was to summarize the overall diagnostic capacity of lncRNA MALAT1 in cancer detection and diagnosis. Methods: Eligible studies satisfying the inclusion criteria were screened and selected from the online database. All statistical analyses were performed using Stata 14.0. Results: A total of 17 eligible studies were included in this pooled analysis, with 1777 cases and 1478 controls. The overall results were shown as follows: sensitivity, 0.74 (95% CI=0.65– 0.81), specificity, 0.79 (95% CI=0.73– 0.84), positive likelihood ratio (PLR), 3.48 (95% CI=2.79– 4.32), negative likelihood, 0.33 (95% CI=0.25– 0.44), diagnostic score, 2.34 (95% CI=1.99– 2.69), diagnostic odds ratio, 10.41 (95% CI=7.33– 14.78) and area under the curve, 0.83 (95% CI=0.80– 0.86). Deeks’ funnel plot asymmetry test (p = 0.66) suggested no potential publication bias. Conclusion: All these results indicate that lncRNA MALAT1 achieves a relatively moderate accuracy in cancer detection and diagnosis, and could serve as a diagnostic biomarker for cancers.Keywords
This publication has 39 references indexed in Scilit:
- MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell LinesJournal of Biological Chemistry, 2017
- A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancerLife Sciences, 2016
- Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancerBMC Research Notes, 2013
- Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancerEuropean Journal of Cancer, 2013
- Structure and function of long noncoding RNAs in epigenetic regulationNature Structural & Molecular Biology, 2013
- Loss of the abundant nuclear non-coding RNAMALAT1is compatible with life and developmentRNA Biology, 2012
- Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challengeHepatology, 2011
- A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancerAnti-Cancer Drugs, 2007
- MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancerOncogene, 2003
- A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluationsStatistics in Medicine, 2001